APA সাইটেশন

Chu, T., Zhang, R., Yang, J., Chao, M. P., Shami, P. J., & Kopeček, J. (2015). A Two-Step Pretargeted Nanotherapy for CD20 Crosslinking May Achieve Superior Anti-Lymphoma Efficacy to Rituximab. Theranostics.

শিকাগো স্টাইলে সাইটেশন

Chu, Te-Wei, Rui Zhang, Jiyuan Yang, Mark P. Chao, Paul J. Shami, এবং Jindřich Kopeček. "A Two-Step Pretargeted Nanotherapy for CD20 Crosslinking May Achieve Superior Anti-Lymphoma Efficacy to Rituximab." Theranostics 2015.

এমএলএ সাইটেশন

Chu, Te-Wei, et al. "A Two-Step Pretargeted Nanotherapy for CD20 Crosslinking May Achieve Superior Anti-Lymphoma Efficacy to Rituximab." Theranostics 2015.